
Opinion|Videos|May 19, 2025
Strengths and Weaknesses of Imaging Modalities in ccRCC
Explore the strengths and weaknesses of imaging modalities like CT, MRI, and ultrasound in diagnosing ccRCC and enhancing patient care.
Advertisement
Episodes in this series

Strengths and Limitations of Different Imaging Modalities
Main Discussion Topics:
- CT scans remain the most common initial imaging modality for renal mass detection.
- MRI offers additional sequencing capabilities for better tumor characterization.
- Ultrasound primarily helps determine whether masses are solid or cystic.
- Nuclear imaging (prostate-specific membrane antigen [PSMA] scans) shows potential but has demonstrated limited accuracy.
Key Points for Physicians:
- CT is widely available and familiar to most clinicians.
- MRI provides superior soft tissue characterization and additional sequences.
- Ultrasound is useful for determining whether a mass is solid vs cystic.
- Nuclear medicine studies such as PSMA scans have not demonstrated sufficient accuracy.
Notable Insights:
Each imaging modality has specific advantages, but many patients arrive with inadequate initial imaging, requiring additional studies for proper characterization.
Clinical Significance:
Understanding the strengths and limitations of each imaging modality allows clinicians to select appropriate studies for comprehensive renal mass evaluation.
Advertisement
Related to this article

OpenFlo incorporates a design that modifies key mechanical features of conventional Foley catheters.

Study design discussions can help patients weigh personalized marketing claims, according to Jean Cunningham, PharmD, BCPS.

VIR-5500 is a PSMA-targeted PRO-XTEN dual-masked T-cell engager entering phase 3 development for prostate cancer.

Marie-Pier St-Laurent, MD, FRCSC, explains how NeoBLAST combines imaging, TURBT, and ctDNA to identify candidates for bladder-sparing surveillance.

Bladder symptoms during IVF often reflect hormonal and pelvic floor changes, not infection, according to Aleece Fosnight, MSPAS, PA-C.

A national survey found US hospitals expanded CAUTI prevention over 20 years, but use of key catheter-removal strategies remains variable.

Rezūm improved symptoms and quality of life at 1 year vs combination pharmacotherapy in sexually active men with BPO while preserving sexual function.
Advertisement
Advertisement

